Fumio Imamura

Shanghai Institute for Science of Science — China

Medicine · Health Sciences

54h-index22.4kcitations401works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(246), Lung Cancer Research Studies(85), Lung Cancer Diagnosis and Treatment(81), Colorectal Cancer Treatments and Studies(80), Cancer Genomics and Diagnostics(62)

Publications399 total

Supplementary Table S2 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Supplementary Figure S2 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Supplementary Figure S5 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Supplementary Table S1 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Supplementary Figure S3 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Supplementary Figure S4 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Supplementary Figure S1 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Supplementary Figure S6 from Early Clearance of Plasma <i>Epidermal Growth Factor Receptor</i> Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2025Open Access
Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high‐frequency <scp>PIK3CA</scp> mutations revealed by molecular and immunohistochemical analysis
Histopathology·2025
Independence and Coherence in Temporal Sequence Computation across the Fronto-Parietal Network
2025Open Access
Ground tilt representation in the rodent cerebral cortex
2025Open Access
Independence and Coherence in Temporal Sequence Computation across the Fronto-Parietal Network
2025· 1 citedOpen Access
Open-source modular FPGA system for two-photon mesoscope enabling multi-layer, multi-depth neural activity recording and lifetime imaging
2025· 2 citedOpen Access
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
Frontiers in Oncology·2025· 1 citedOpen Access
Supplementary Table S2 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2024Open Access
Supplementary Figure S6 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2024Open Access
Supplementary Figure S2 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2024Open Access
Supplementary Figure S1 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2024Open Access
Supplementary Figure S3 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2024Open Access
Supplementary Figure S6 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
2024Open Access
page 1 of 20Next →

Frequent Co-authors

Kazuhiko Nakagawa(13), Toru Kumagai(12), Takashi Seto(11), Isamu Okamoto(10), Yuichiro Ohe(9), Nobuyuki Yamamoto(9), Masahiko Higashiyama(9), Byoung Chul Cho(8), Suresh S. Ramalingam(8), Kazumi Nishino(8), Jhanelle E. Gray(7), Toyoaki Hida(7), Makoto Nishio(7), Shinji Atagi(7), Junji Uchida(7), Takako Inoue(7), Naoyuki Nogami(6), Takayasu Kurata(6), Ying Cheng(6), Rachel Hodge(6)